Virtual Medicinal Product (VMP)
-
Generic COVID-19 Vaccine VidPrevtyn Beta (CoV2 preS dTM monovalent B.1.351 [recombinant adjuvanted]) 5micrograms/0.5ml dose solution and emulsion for emulsion for injection multidose vials
Name Details
Current Name
Generic COVID-19 Vaccine VidPrevtyn Beta (CoV2 preS dTM monovalent B.1.351 [recombinant adjuvanted]) 5micrograms/0.5ml dose solution and emulsion for emulsion for injection multidose vials
|
Start Date
10-01-2023
|
End Date
|
Previous Name
Generic COVID-19 Vaccine Sanofi (CoV2 preS dTM monovalent B.1.351 [recombinant adjuvanted]) 5micrograms/0.5ml dose emulsion for injection multidose vials
|
Start Date
04-08-2022
|
End Date
09-01-2023
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 0.5
- UDFS UOM
- ml
- Unit Dose UOM
- dose
Summary
- Prescribing Status
- Never Valid To Prescribe As A VMP
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular
- Form
- Solution and emulsion for emulsion for injection
- Ontology Form/Route
- emulsioninjection.intramuscular
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- Other
Codes
- ATC Code
-
n/a
SNOMED Codes
Code
|
Start Date
|
End Date
|
40872511000001107 |
04-08-2022 |
|
Virtual Medicinal Product Pack (VMPP) Information